Uurimisrühmad - Stabilis 4.0

1

Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C.
Shead K, Derrick H, Lyons D, Law S, Ma N.H. ()
- 2023 -

2

Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers.
Ma NH, Charbonneau LF, Law S, Walker S. ()
Sunnybrook Healt Science Centre - 2023 -

3

Stability of Voriconazole 10 mg/mL in IsoptoTears 0.5% stored in Glass Vials And Low Density Polyethylene Droppers at 4°C and 25°C for 28 Days.
Perks B, Law S, Ma N. ()
- 2023 -

4

Stability of Dr.Reddy’s Cabazitaxel Following Reconstitution with Manufacturer’s Diluent & Dilution with Sodium Chloride and Dextrose 5% in non-PVC non-DEHP bags and Original Glass Vials at 25°C, 4°C and -20°C.
H Ma N, Law S, Walker S. ()
- 2023 -

5

Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles.
Walker SE, Sachedina H, Bichar K. ()
Can J Hosp Pharm - 2021 - ;74(3):227-34

6

Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes.
Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE. (lee.dupuis@sickkids.ca)
J Oncol Pharm Practice - 2021 - ;27,1:78–87

7

Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C)
Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2021 - ;74;1:57-69

8

Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
Walsh A, Ziegler B, Lingertat-Walsh K, Law S, Walker S. (karen.walsh@sickkids.ca)
Int J Pharm Compound - 2021 - ;25,2:163-168

9

Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C.
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E. ()
Sunnybrook Health Sciences Centre - 2020 -

10

Stability of Morphine Solutions of 20, 40, 100 , 200 and 1,000 µg/mL in Syringes Following Dilution with 0.9% Sodium Chloride or D5W at Room Temperature (25°C).
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E. ()
Sunnybrook Health Sciences Centre - 2020 -

11

Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC).
Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE. ()
Sunnybrook - 2019 -

12

Stability of 20,40 and 50 microg/mL Fentanyl Solutions Stored in Syringes at Room Temperature (23°C).
Riss V, Hook R, Neault A, Scharrer E, Law s, Walker S.E. (scott.walker@sunnybrook.ca)
Prof Practice Conference - Canadian Society of PH - 2019 -

13

Stability of Azacitidine Solutions In Sterile Water for Injection.
Tyono I, Law S, Charbonneau L.F, Walker S.E. (scott.walker@sunnybrook.ca)
Prof Practice Conference - Canadian Society of PH - 2019 -

14

Chemical Stability of Cloxacillin in Sterile Water for Injection (SWFI) Stored in Polypropylene (PP) Syringes (50 and 100 mg/mL) and Glass Vials (250 mg/mL) at 4°C and 25°C.
Perks W, Marchensano R, Law S, Iazetta J, Walker SE. ()
- 2019 -

15

Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE. ()
- 2019 -

16

Stability of 2.5mg/mL Indocyanine Green (ICG) Solutions Stored in Syringes at 25ºC, 4ºC, -20ºC and -67ºC.
Perks W, Law S, Marchesano R, Walker SE. ()
- 2019 -

17

Stability of 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C)
Roxanne Hook, Vera Riss, Erica Scharrer, Shirley Law and Scott E. Walker (scott.walker@sunnybrook.ca)
Professional Practice Conference - Canadian Societ - 2018 -

18

Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags.
Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2017 - ; 70,1 : 7-12.

19

Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C).
Law S, Perks W, Iazetta J, Walker S. (scott.walker@sunnybrook.ca)
Prof Practice Conference - Canadian Society of PH - 2017 -

20

Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
Ma N, Perks W, Law S, John I, Walker S. (scott.walker@sunnybrook.ca)
Int J Pharm Compound - 2017 - ;24,6:519-527

21

Stability of 0.2 and 10 mg/mL Hydromorphone Solutions In CADD reservoirs, PVC and Ethylene/Propylene Co-Polymer (PAB) Bags at Room Temperature (23°C°).
Perls W, Law S, Iazetta J, Walker S. (scott.walker@sunnybrook.ca)
Prof Practice Conference - Canadian Society of PH - 2017 -

22

Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Walker S.E, Law S, Perks W, Iazzetta J. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2015 - ; 68, 2: 121-126.

23

Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C).
Walker S.E, Charbonneau L.F, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2014 - ; 67, 2: 102-107

24

Stability of Azacitidine in Sterile Water for Injection.
Walker S.E, Charbonneau L.F, Law S, Earle C. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2012 - ; 65, 5: 352-359

25

Stability of Norepinephrine Solutions in Normal Saline and 5% Dextrose in Water.
Walker SE, Law S, Garland J, Fung E, Iazzetta J. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2010 - ; 63, 2: 113-118.

26

Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C
Walker S.E, Iazzetta J, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2009 - ; 62, 2: 135-141.

27

Stability of an extemporaneous oral liquid aprepitant formulation.
Dupuis LL, Lingertat-Walsh K, Walker SE. (scott.walker@sunnybrook.ca)
Support Care Cancer - 2009 - ; 17, 6: 701-706.

28

Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Battistella M, Walker S, law S, Lok C. ()
Hemodial Int - 2009 - ; 13, 3: 322-328.

29

Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C)
Walker SE, Milliken D, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2008 - ; 61, 1: 14-20.

30

Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Walker S.E, Charbonneau F, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2007 - ; 60, 4: 231-237.

31

Stability of sulfasalazine oral suspension.
Linger-Walsh K, Walker SE, Law S, Abesamis M, Sales P. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2006 - ; 59, 4: 194-200.

32

Visual compatibility of gentamicin sulfate and 4% sodium citrate solutions.
Wazny L, Walker S, Moist L. ()
Am J Health-Syst Pharm - 2005 - ; 62: 1548-1550.

33

Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers.
Walker SE, Shirley L, Puodziunas A. ()
Can J Hosp Pharm - 2005 - ; 58: 212-222.

34

Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Walker S.E, Law S, Puodziunas A. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2005 - ; 58, 4: 212-222.

35

Stability of clozapine stored in oral suspension vehicles at room temperature.
Walker SE, Baker D, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2005 - ; 58, 5: 279-284.

36

Physical compatibility of pantoprazole with selected medications during simulated Y-site administration.
Walker SE, Wyllie A, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2004 - ; 57, 2: 90-96.

37

Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water.
Chan J, Walker SE, Law S. ()
Can J Hosp Pharm - 2003 - ; 56, 2: 87-92.

38

Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions.
Walker SE, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2002 - ; 55: 27-38.

39

Stability of oxycodone hydrochloride for injection in dextrose and saline solutions.
Turnbull K, Bielech M, Walker SE, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2002 - ; 55: 272-277.

40

Compatibility of oxytocin, zidovudine, and penicillin G.
Oliver C, Law S. ()
Can J Hosp Pharm - 2001 - ; 54: 112-113.

41

Stability of preservative-free tobramycin in half-normal saline.
Law S. ()
Can J Hosp Pharm - 2001 - ; 54, 3: 214-215.

42

Stability and compatibility of etoposide in normal saline.
Lepage R, Walker SE, Godin J. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2000 - ; 53: 338-345.

43

Stability of ketorolac tromethamine in IV solutions and waste reduction.
Shi A, Walker SE, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2000 - ; 53: 263-269.

44

Concentration-dependant compatibility and stability of dexamethasone and midazolam.
Wong AH, Law S, Walker SE, Bowles SK. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 2000 - ; 53: 24-31.

45

Stability of reconstituted indomethacin sodium trihydrate in original vials and polypropylene syringes.
Walker SE, Gray S, Schmidt B. (scott.walker@sunnybrook.ca)
Am J Health-Syst Pharm - 1998 - ; 55: 154-158.

46

Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride.
Walker SE, Varrin S, Yannicelli D, Law S. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1998 - ; 51: 156-168.

47

Stability and compatibility of morphine with bupivacaine.
Shiffman E, Walker SE, Yoon T, Yeung M. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1998 - ; 51: 110-116.

48

Concentration and solution dependent stability of cloxacillin intravenous solutions.
Walker SE, Dufour A, Iazetta J. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1998 - ; 51: 13-19.

49

Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity.
Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE. (scott.walker@sunnybrook.ca)
Antimicrob Agents Chemother - 1998 - ; 42: 762-766.

50

Stability of parenteral midazolam in an oral formulation.
Walker SE, Grad HA, Haas DA, Mayer A. (scott.walker@sunnybrook.ca)
Anest Prog - 1997 - ; 44, 1: 17-22.

51

Compatibility of selected critical care drugs during Y-site administration.
Yamashita SK, Walker SE, Choudhury T, Iazzetta J. (scott.walker@sunnybrook.ca)
Am J Health-Syst Pharm - 1996 - ; 53: 1048-1051.

52

Stability and compatibility of reconstituted sterile hydromorphone with midazolam.
Walker SE, Meinders A, Tailor H. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1996 - ; 49: 290-298.

53

Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DWC, Law S, Walker SE, Iazzetta J. (scott.walker@sunnybrook.ca)
PDA J Pharm Sci Technol - 1996 - ; 50: 261-267.

54

Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin.
Avelar MA, Walker SE. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1996 - ; 49: 140-145.

55

Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine.
Walker SE, Iazetta J, DeAngelis C, Lau DWC. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1993 - ; 46: 61-65.

56

Compatibility and stability of hyaluronidase and hydromorphone.
Walker SE, Lau DWC. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1992 - ; 45: 187-192.

57

Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions.
Walker SE, Paton TW, Oreopoulos DG. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1992 - ; 45: 237-242.

58

Stability and compatibility of combinations of hydromorphone and a second drug.
Walker SE, DeAngelis C, Iazzetta J. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1991 - ; 44: 289-295.

59

Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
Walker SE, DeAngelis C, Iazzetta J, Eppel JG. (scott.walker@sunnybrook.ca)
Am J Hosp Pharm - 1991 - ; 48: 2161-2166.

60

Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker S, Lau D, DeAngelis C, Iazetta J, Coons C. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1991 - ; 44: 71-78.

61

Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1990 - ; 43: 265-272.

62

Famotidine stability in total parenteral nutrient solutions.
Walker SE, Iazetta J, Lau DWC, Madorin PL. ()
Can J Hosp Pharm - 1989 - ; 42: 97-103.

63

Stability of sulfite free high potency morphine sulfate solutions in portable infusion pump cassettes.
Walker SE, Iazzetta J, Lau DWC. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1989 - ; 42: 195-200.

64

Hydromorphone and morphine stability in portable infusion pump cassettes and minibags.
Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1988 - ; 41: 177-182.

65

The stability of morphine intravenous infusion solutions.
Vecchio M, Walker SE, Iazzetta J, Hardy BG. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1988 - ; 41: 5-9.

66

Stability of ranitidine hydrochloride admixtures refrigerated in polyvinyl chloride minibags.
Walker SE, Kirby K. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1988 - ; 41: 105-108.

67

Stability of intravenous vancomycin.
Walker SE, Birkhans B. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1988 - ; 41: 233-238, 242.

68

Ceftazidime stability in normal saline and dextrose in water.
Walker SE, Dratnitsaris G. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1988 - ; 41: 65-71.

69

Stability of reconstituted ceftriaxone in dextrose and saline solutions.
Walker SE, Dranitsaris G. (scott.walker@sunnybrook.ca)
Can J Hosp Pharm - 1987 - ; 40: 161-166.

70

Stability and availability of cyclosporine stored in plastic syringes.
Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R. (scott.walker@sunnybrook.ca)
Am J Hosp Pharm - 1986 - ; 43: 692-694.

71

Stability of ranitidine hydrochloride in total parenteral nutrient solution.
Walker SE, Bayliff CD. ()
Am J Hosp Pharm - 1985 - ; 42: 590-592.

72

Stability and sterility of cimetidine admixtures frozen in minibags.
Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE. (scott.walker@sunnybrook.ca)
Am J Hosp Pharm - 1981 - ; 38: 881-883.